GlobeNewswire by notified

BioGX Launches 'pixl™' Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases

Share

BIRMINGHAM, Ala., Dec. 08, 2022 (GLOBE NEWSWIRE) -- BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced the Ex-US commercial release of its portable pixl™ qPCR real-time PCR platform for use with BioGX CE-IVD marked assays, enabling global access and complementing the recent US FDA EUA expanded use of Xfree™ COVID-19 Direct RT-PCR on the pixl.

The pixl instrument is a benchtop 4-channel, 16-well, RT-PCR instrument that supports rapid turnaround times for batches of up to 16 samples, with integrated results interpretation on a device with the compact footprint of a touchpad.

"pixl, combined with our unique Xfree chemistry, offers a low-cost direct-sample-to-answer PCR solution on a portable, compact device. pixl will provide broader access to clinical laboratories for decentralized PCR testing, enabling faster, better, low-cost near-patient molecular diagnostics," said Shazi Iqbal, Ph.D., CEO of BioGX.

This platform was previously CE-IVD marked and can be used with the following BioGX CE-IVD marked assays:

  • Xfree COVID-19 (N1-gene) Direct RT-PCR
  • Xfree COVID-19 (N1/RdRp), Flu A, Flu B
  • Xfree Group A Streptococcus

Starting January 2023, BioGX will make additional syndromic tests available on the pixl platform from its large menu of lyophilized multiplex assays, including the Research Use Only (RUO) Direct-Sample assays: Xfree Human Monkeypox (hMPXV), Xfree HSV1/HSV2/VZV and Xfree Treponema pallidum (Syphilis). The Xfree assay format is compatible with most commonly used transport/collection media types and can be validated with a wide variety of patient sample collections. 

Additional information can be requested by contacting BioGX at Ph: +1.205.250.8055 or info@biogx.com

About BioGX

BioGX is a leading global provider of lyophilized real-time PCR reagents for molecular diagnostics. BioGX, Inc., headquartered in Birmingham, Alabama, and Dallas, TX, and its wholly owned subsidiary BioGX B.V., based in Amsterdam, The Netherlands, (collectively "BioGX"), operates in a cGMP compliant environment certified to ISO 13485 medical device development and manufacturing standards. The proprietary Sample-Ready technology is at the core of all product offerings for Clinical, Food Safety, Pharma QC and Water Quality molecular testing. BioGX's 60+ multiplex real-time PCR products are marketed and sold in several countries through its Global Distribution Network. 

For more information on BioGX, please visit BioGX.com.

Sample-Ready, Just Add Water, Xfree and pixl are trademarks of BioGX, Inc.

Contact Information:
Mohammed Merchant
Sr. Director, Marketing
marketing@biogx.com
(205) 250-8055

This content was issued through the press release distribution service at Newswire.com.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

OP Mortgage Bank: Financial Statements Bulletin for 1 January–31 December 20228.2.2023 09:00:00 CET | Press release

OP Mortgage Bank Financial Statements Bulletin Stock Exchange Release 8 February 2023 at 10.00 EET OP Mortgage Bank: Financial Statements Bulletin for 1 January–31 December 2022 OP Mortgage Bank (OP MB) is part of OP Financial Group. Together with OP Corporate Bank plc, its role is to raise funding for OP from money and capital markets. OP MB is responsible for the Group’s funding with regard to covered bond issuance. Financial standing The intermediary loans and loan portfolio of OP MB totalled EUR 19,620 million (18,275)* on 31 December 2022. Bonds issued by OP MB totalled EUR 18,165 million (16,415) at the end of December 2022. In April, OP MB issued a green covered bond in the international capital market. The fixed-rate one-billion-euro covered bond has a maturity of five and a half years. All proceeds of the bonds were intermediated to 98 OP cooperative banks in the form of intermediary loans. In June, OP MB issued a one-billion-euro retained covered bond with a maturity of one y

Hexagon Composites ASA: Invitation to fourth quarter and full-year 2022 results8.2.2023 09:00:00 CET | Press release

08 February 2023: Hexagon Composites ASA's fourth quarter and full-year 2022 results will be released on 16 February 2023 at 07:00 am CET. Jon Erik Engeset, CEO and David Bandele, CFO will present the results at 08:30 am the same morning. The presentation will be held in the Auditorium at Hexagon's location in Oslo, Haakon VIIs gate 2, on the lower level. If you would like to attend the presentation, please pre-register by emailing ir@hexagongroup.com, alternatively register upon arrival. The presentation will also be broadcasted live via: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230216_7 For further information: Ingrid Aarsnes, VP Investor Relations and ESG, Hexagon Composites ASA Telephone: +47 950 38 364 | ingrid.aarsnes@hexagongroup.com About Hexagon Composites ASA Hexagon delivers safe and innovative solutions for a cleaner energy future. Our solutions enable storage, transportation and conversion to clean energy in a wide range of mobility, industrial and consum

Nøkkelinformasjon ved kontantutbytte for Aurskog Sparebank8.2.2023 08:23:20 CET | Pressemelding

Utbyttebeløp: NOK 10,00 Annonsert valuta: NOK Siste dag inklusive: 08.03.23 Ex dato: 09.03.23 Record date (eierregisterdato): 10.03.23 Betalingsdato: 22.03.23 Vedtaksdato: 08.03.23 Informasjonen samsvarer med foreslått disponering i offentliggjort delårsrapport pr 31.12.22. Årsrapporten sluttbehandles av styret 01.03.23 og representantskapet behandler årsregnskap og disponering 08.03.23. Denne informasjonen offentliggjøres i henhold til kravene i Løpende forpliktelser.

Upgraded outlook for 20238.2.2023 08:09:58 CET | Press release

Jyske Bank expects earnings per share of DKK 60-70, corresponding to a net profit of DKK 4.0bn - 4.6bn and a profit before tax of DKK 5.3bn - 6.1bn in 2023. The intervals include one-off costs related to the integration of Handelsbanken Denmark, which are expected to amount to c. DKK 0.3bn. The outlook reflects the effects of the acquisition of Handelsbanken Denmark, the higher level of interest rates as well as a continued solid credit quality. The integration of the former Handelsbanken Denmark is progressing according to plan, both financially, commercially and organizationally. Previously, Jyske Bank expected earnings per share of DKK 55-65, corresponding to a net profit of DKK 3.7bn - 4.3bn in 2023. Yours faithfully, Jyske Bank Contact person: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44. Attachment Corporate Announcement_20230208

Opjustering af forventet resultat i 20238.2.2023 08:09:58 CET | pressemeddelelse

Jyske Bank forventer et resultat pr. aktie på 60-70 kr., svarende til et resultat efter skat på 4,0-4,6 mia. kr. i 2023. Resultatintervallet før skat er 5,3-6,1 mia. kr. Forventningerne er inklusive integrations- og restruktureringsomkostninger i forbindelse med købet af Handelsbanken Danmark på ca. 0,3 mia. kr. Forventningerne afspejler helårseffekten af købet af Handelsbanken Danmark, det højere renteniveau og en fortsat solid kreditkvalitet. Sammenlægningen med det tidligere Handelsbanken Danmark forløber planmæssigt såvel økonomisk, forretningsmæssigt som organisatorisk. Tidligere var forventningerne et resultat pr. aktie på 55-65 kr., svarende til et resultat efter skat på 3,7-4,3 mia. kr. i 2023. Venlig hilsen Jyske Bank Kontaktperson: Birger Krøgh Nielsen, CFO, tlf. +45 89 89 64 44. Vedhæftet fil Selskabsmeddelelse_20230208